This study investigated the effect of a 22-hour fast on glucagon and glucose metabolism in healthy humans. It found that fasting lowered glucagon levels and endogenous glucose production under both normal and low blood sugar conditions.
JCI Insight · 9 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This study investigated the effect of a 22-hour fast on glucagon and glucose metabolism in healthy humans. It found that fasting lowered glucagon levels and endogenous glucose production under both normal and low blood sugar conditions.
The central result was that fasting reduced hepatic glycogen content by 42%, which was associated with lower glucagon levels and diminished endogenous glucose production under both euglycemic and hypoglycemic conditions. The glucagon response to hypoglycemia itself did not differ between treatments. Limitations include the study of healthy individuals rather than those with type 1 diabetes, assessment of only a single fasting day, and an uneven sex distribution. The findings suggest fasting may increase hypoglycemia susceptibility in humans through an insulin-independent reduction in the counterregulatory hormone response.